EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer

Nurhan Onal Kalkan iD, Zuhat Urakcı, Berrak Mermit Erçek, Erkan Bilen, Hayati Arvas, Mehmet Hadi Akkuş

Journal of Clinical Medicine · 06.11.2025 · 14 (21) · 7885

DOI: 10.3390/jcm14217885 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.11.2025. Verfasst von Nurhan Onal Kalkan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Batman Training and Research Hospital, 72070 Batman, Turkey. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endometrial cancer (EC) is the most common gynecological malignancy in developed countries. While early-stage disease has favorable outcomes, advanced or recurrent EC remains associated with poor prognosis. Novel prognostic markers are needed to refine risk stratification. Systemic inflammation-based indices such as Pan-Immune Inflammation Value (PIV), Systemic Inflammation Response Index (SIRI), and Systemic Immune Inflammation Index (SII) have shown prognostic potential in solid tumors.

Methods

We retrospectively evaluated 78 patients with endometrioid EC who had undergone hysterectomy with adnexectomy and lymphadenectomy. Demographic, clinicopathological, and laboratory data were extracted from electronic medical records. PIV, SII, and SIRI were calculated from the preoperative complete blood counts. Survival was assessed using Kaplan–Meier analysis, while prognostic factors were determined using univariate and multivariate Cox regression analyses.

Results

The median age was 59 years, and 64.1% of the patients presented with early-stage disease. A high PIV (≥802) was significantly associated with a shorter overall survival (64 vs. 111 months, p < 0.001). PIV demonstrated the highest discriminatory accuracy (AUC = 0.776), followed by the SII (0.747) and SIRI (0.718). Univariate analysis identified that age, grade, LVSI, PNI, stage, distant metastasis, and high PIV, SII, SIRI, and NLR were predictors of poor survival. Multivariate analysis confirmed grade, distant metastasis and SIRI ≥ 1.5 as independent prognostic factors.

Conclusions

Inflammation-based indices, particularly PIV and SIRI, correlated with survival outcomes in patients with EC. The SIRI retained an independent prognostic value, whereas PIV showed a strong discriminatory capacity. Incorporating these indices into established risk models may improve prognostic precision and support individualized management.

Schlagwörter

Stichwörter der Autor:innen

PIVSIISIRIendometrial cancerprognosissystemic inflammation

Autor:innen und Institutionen

  • Department of Medical Oncology, Batman Training and Research Hospital, 72070 Batman, Turkey.
  • Department of Medical Oncology, Faculty of Medicine, Dicle University, 21280 Diyarbakır, Turkey.
  • Department of Medical Oncology, Faculty of Medicine, Yuzuncu Yil University, 65090 Van, Turkey.

ORCID-Profile: Nurhan Onal Kalkan

Zitieren

APA

Onal Kalkan, N., Urakcı, Z., Mermit Erçek, B., Bilen, E., Arvas, H., & Akkuş, M. H. (2025). Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer. Journal of Clinical Medicine, 14(21), 7885. https://doi.org/10.3390/jcm14217885

Vancouver

Onal Kalkan N, Urakcı Z, Mermit Erçek B, Bilen E, Arvas H, Akkuş MH. Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer. Journal of Clinical Medicine. 2025;14(21):7885. doi:10.3390/jcm14217885

BibTeX
@article{OnalKalkan2025,
  author = {Onal Kalkan, Nurhan and Urakcı, Zuhat and Mermit Erçek, Berrak and Bilen, Erkan and Arvas, Hayati and Akkuş, Mehmet Hadi},
  title = {Clinical Utility of Pan-Immune Inflammation Value (PIV) in Predicting Prognosis of Endometrial Cancer},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {21},
  pages = {7885},
  doi = {10.3390/jcm14217885}
}
Kostenlos starten →